Kevin G. Buda

Kevin G. Buda

Auto-generated profile, based on publicly available information

Kevin G. Buda

Mayo College of Medicine

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2022 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
MMMichael Megaly
Michael Megaly
KBKevin Buda
Kevin Buda
KMKambis Mashayekhi
Kambis Mashayekhi
GWGerald Werner
Gerald Werner
JGJ. Aaron Grantham
J. Aaron Grantham
KAKhaldoon Alaswad
Khaldoon Alaswad

19 March 2024 in European Heart Journal: Acute Cardiovascular Care
Verified
Journal Article
Closed access
PDF file
KBKevin G Buda
Kevin G Buda
KHKatarzyna Hryniewicz
Katarzyna Hryniewicz
PEPeter M Eckman
Peter M Eckman
MBMir B Basir
Mir B Basir
JCJennifer A Cowger
Jennifer A Cowger
MMMichael S Megaly
Michael S Megaly
Aims: Despite increased temporary mechanical circulatory support (tMCS) utilization for acute myocardial infarction complicated by cardiogenic shock (AMI-CS), data regarding efficacy and optimal timing for tMCS support are limited. This study aimed to describe outcomes based on tMCS timing in AMI-CS and to identify predictors of 30-day mortality and readmission. Methods and results: Patients with AMI-CS identified in the National Readmissions Database were grouped according to the use of tMCS and early (<24 h) vs. delayed (≥24 h) tMCS. The correlation between tMCS timing and inpatient outcomes was evaluated using linear regression. Multivariate logistic regression was used to identify variables associated with 30-day mortality and readmission. Of 294 839 patients with AMI-CS, 109 148 patients were supported with tMCS (8067 veno-arterial extracorporeal membrane oxygenation, 33 577 Impella, and 79 161 intra-aortic balloon pump). Of patients requiring tMCS, patients who received early tMCS (n = 79 906) had shorter lengths of stay (7 vs. 15 days, P < 0.001) and lower rates of ischaemic and bleeding complications than those with delayed tMCS (n = 32 241). Patients requiring tMCS had higher in-hospital mortality [odds ratio (95% confidence interval)] [1.7 (1.7–1.8), P < 0.001]. Among patients requiring tMCS, early support was associated with fewer complications, lower mortality [0.90 (0.85–0.94), P < 0.001], and fewer 30-day readmissions [0.91 (0.85–0.97), P = 0.005] compared with patients with delayed tMCS. Conclusion: Among patients receiving tMCS for AMI-CS, early tMCS was associated with fewer complications, shorter lengths of stay, lower hospital costs, and fewer deaths and readmissions at 30 days.

28 June 2024 in ASAIO Journal
Verified
Journal Article
Closed access
KBKevin G. Buda
Kevin G. Buda
EREmilie C. Robinson
Emilie C. Robinson
JTJessica Titus
Jessica Titus
PEPeter M. Eckman
Peter M. Eckman
ICIvan Chavez
Ivan Chavez
KHKatarzyna Hryniewicz
Katarzyna Hryniewicz
Although current studies support the use of prophylactic distal perfusion catheters (DPCs) to decrease limb ischemia in patients on venoarterial extracorporeal membrane oxygenation (VA ECMO), methods for monitoring limb ischemia differ between studies. We evaluated the safety of a selective rather than prophylactic DPC strategy at a single center with a well-established protocol for limb ischemia monitoring. Distal perfusion catheters were placed selectively if there was evidence of hypoperfusion at any point until decannulation. All patients were followed daily by vascular surgery with continuous regional saturation monitoring. Of 188 patients supported with VA ECMO, there were no significant differences in baseline characteristics between patients with upfront, delayed, and no DPC. Thirty day mortality was highest in patients with an upfront DPC (56% in the upfront DPC group, 19% in the delayed DPC group, and 22% in the no-DPC group, p < 0.001). The incidence of major bleeding, fasciotomy, and amputation in the entire cohort was 3.7%, 3.7%, and 0%, respectively. With strict adherence to a protocol for limb ischemia monitoring, a selective rather than prophylactic DPC strategy is safe and may obviate the risks of an additional arterial catheter.

2 May 2022 in Cleveland Clinic Journal of Medicine
Verified
Journal Article
Open access
PDF file
AHAbel Hooker
Abel Hooker
KBKevin G. Buda
Kevin G. Buda
MPMaarya Pasha
Maarya Pasha
The 2017 American College of Cardiology and American Heart Association Task Force on Clinical Practice Guidelines on the treatment of hypertension recommended lifestyle modification and monitoring every 3 to 6 months for patients with stage 1 hypertension. However, the guidelines did not include recommendations for patients whose blood pressure is unresponsive to lifestyle therapy. The authors review the updated AHA position statement, which is meant to help clinicians manage patients with stage 1 hypertension and a low 10-year risk of atherosclerotic cardiovascular disease.

11 November 2025 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
KBKevin G. Buda
Kevin G. Buda
AEAndrea Elliott
Andrea Elliott
JBJason Bartos
Jason Bartos
DYDemetri Yannopoulos
Demetri Yannopoulos
RKRajat Kalra
Rajat Kalra

13 June 2024 in JACC: Case Reports
Verified
Journal Article
Open access
KBKevin G. Buda
Kevin G. Buda
NANadhem Abdallah
Nadhem Abdallah
SISebastian Iturra
Sebastian Iturra
KHKatarzyna Hryniewicz
Katarzyna Hryniewicz
A 40-year-old male presented with an inferior ST-segment elevation myocardial infarction. Multimodality imaging identified a ventricular septal defect and a right ventricular free wall dissection. He was bridged with a percutaneous microaxial left ventricular assist device to successful surgical repair. Multimodality imaging, shock team involvement, and mechanical support were critical in ensuring his survival to hospital discharge.